Profil
John Herberger is currently the Vice President-Technical Operations at Eledon Pharmaceuticals, Inc. since 2022.
Prior to this, he worked as a Senior Director-Technology at Spark Therapeutics, Inc.
Postes actifs de John Herberger
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Anciens postes connus de John Herberger
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
